Expression, characterization, and detection of human uridine phosphorylase and identification of variant uridine phosphorolytic activity in selected human tumors

Cancer Research

Volumn 58, Issue 23, 1998, Pages 5418-5424

  Liu, Mengping ^a   Cao, Deliang ^a   Russell, Rosalind ^a   Handschumacher, Robert E ^a   Pizzorno, Giuseppe ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 BENZYLACYCLOURIDINE; ANTINEOPLASTIC AGENT; FLUOROURACIL; POLYCLONAL ANTIBODY; THYMIDINE PHOSPHORYLASE; URACIL; URIDINE; URIDINE PHOSPHORYLASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME INHIBITION; ENZYME KINETICS; ENZYME PURIFICATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOUSE; NONHUMAN; OPEN READING FRAME; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY SPECIFICITY; CLONING, MOLECULAR; DNA, COMPLEMENTARY; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INHIBITORS; FEMALE; HUMANS; KINETICS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEOPLASMS; RABBITS; SEQUENCE HOMOLOGY, AMINO ACID; URACIL; URIDINE; URIDINE PHOSPHORYLASE;

EID: 0032401829     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Cass, C. E., and Paterson, A. R. P. Mediated transport of nucleosides in human erythrocytes. Accelerative exchange diffusion of uridine and thymidine and specificity toward pyrimidine nucleosides as permeants. J. Biol. Chem., 247: 3314-3320, 1972.
2. Cass, C. E., and Paterson, A. R. P. Mediated transport of nucleosides by human erythrocytes. Specificity toward purine nucleosides as permeants. Biochim. Biophys. Acta, 291: 734-746, 1973.
3. Jarvis, S. M., and Young, J. D. Nucleoside translocation in sheep reticulocytes and fetal erythrocytes: a proposed model for the nucleoside transporter. J. Physiol., 324: 47-66, 1982.
4. Wohlhueter, R. M., Marz, R., and Plagemann, P. G. W. Thymidine transport in cultured mammalian cells. Kinetic analysis, temperature dependence and specificity of the transport system. Biochim. Biophys. Acta, 553: 262-283, 1979.
5. Paterson, A. R. P., Jakobs, E. S., Harley, E. R., Cass, C. E., and Robins, M. J. Inhibitors of nucleoside transport as probes and drugs. In: Y. C. Cheng (ed.), Development of Target Oriented Anticancer Drugs, pp. 41-55. New York: Raven Press, 1983.
6. Kuttesch, J. F., Jr., and Nelson, J. A. Renal handling of 2′-deoxyadenosine and adenosine in humans and mice. Chemother. Pharmacol., 8: 221-229, 1982.
7. Kuttesch, J. F., Jr., Robins, M. J., and Nelson, J. A. Renal transport of 2′-deoxytubercidin in mice. Biochem. Pharmacol., 31: 3387-3394, 1982.
8. LeHir, M., and Dubach, U. C. Uphill transport of pyrimidine nucleosides in renal brush border vesicles. Pfugers Arch., 404: 238-243, 1985.
9. +-dependent uridine transport in rat renal brush border membrane vesicles. Biochim. Biophys. Acta, 942: 139-149, 1988.
10. Trimble, and Coulson, R. Adenosine transport in perfused rat kidney and renal cortical membrane vesicles. Am. J. Physiol., 246: F794-F803, 1984.
11. Jarvis, S. M., Williams, T. C., Lee, C., and Wand Cheeseman, C. I. Active transport of nucleosides and nucleoside drugs. Biochem. Soc. Trans., 17: 448-4449, 1989.
12. Darnowski, J. W., and Handschumacher, R. E. Tissue uridine pools: evidence in vivo of a concentrative mechanism for uridine uptake. Cancer Res., 46: 3490-3494, 1986.
13. Dagnino, L., Bennett, L. L., Jr., and Paterson, A. R. P. Sodium-dependent nucleoside transport in mouse leukemia L1210 cells. J. Biol. Chem., 266: 6308-6311, 1991.
14. Krenisky, T. A., Barclay, M., and Jacquez, J. A. Specificity of mouse uridine phosphorylase. Chromatography, purification and properties. J. Biol. Chem., 239: 805-812, 1964.
15. Krenisky, T. A., Mellors, J. W., and Barclay, R. K. Pyrimidine nucleosidases, their classification and relationship to uric acid ribonucleoside phosphorylase. J. Biol. Chem., 240: 1281-1286, 1965.
16. Niedzwicki J. G., El Kouni, M. D., Chu, S. H., and Cha, S. Pyrimidine acyclonucleosides inhibitors of uridine phosphorylase. Biochem. Pharmacol., 30: 2097-2101, 1981.
17. Niedzwicki, J. G., Chu, S. H., El Kouni, M. H., Rowe, E. C., and Cha, S. 5-Benzylacyclouridine and 5-benzyloxybenzylacycloruridine, potent inhibitors of uridine phosphorylase. Biochem. Pharmacol., 31: 1857-1861, 1982.
18. Pontis, H., Degerstedt, G., and Reichard, P. Uridine and deoxyuridine phosphorylase from Ehrlich ascites tumor. Biochim. Biophys. Acta, 51: 138-147, 1961.
19. Mukherjee, K. L., Boohar, J., Wentland, D., Ansfield, F. J., and Heidelberger, C. Studies on fluorinated pyrimidines. XVI. Metabolism of 5-fluorouracil-2-C14 and 5-fluoro-2′-deoxyuridine-2-C14 in cancer patients. Cancer Res., 23: 49-66, 1963.
20. Birnie, G. D., Kroeger, H., and Heidelberger, C. Studies of fluorinated pyrimidines. XVIII. The degradation of 5-fluoro-2′-deoxyuridine and related compounds by nucleoside phosphorylase. Biochemistry, 2: 566-572, 1963.
21. Darnowski, J. W., and Handschumacher, R. E. Tissue-specific enhancement of uridine utilization and 5-fluorouracil therapy in mice by benzylacyclouridine. Cancer Res., 45: 5364-5368, 1985.
22. Chu, S. Y., Weng, Z. Y., Chen, Z. H., Rowe, E. C., Chu, E., Naguib, F. N. M., el Kouni, M. H., Cha, S., and Chu, M. Y. Synthesis of 5-benzyl and 5-benzyloxybenzyl 2,2′-anhydrouridines and related nucleoside analogs as inhibitors of uridine phosphorylase. Nucleosides Nucleotides, 7: 91-102, 1988.
23. Monks, A., Ayers, O., and Cysyk, R. L. Effect of 5-benzylacyclouridine, a potent inhibitor of uridine phosphorylase, on the metabolism of circulating uridine by the isolated rat liver. Biochem. Pharmacol., 32: 2003-2009, 1983.
24. Martin, D. S., Stolfi, R. L., and Sawyer, R. C. Use of oral uridine as substitute for parenteral uridine rescue of 5-fluorouracil therapy, with and without the uridine phosphorylase inhibitor 5-benzylacyclouridine. Cancer Chemother. Pharmacol., 24: 9-14, 1989.
25. Leyva, A., van Groeningen, C. J., Kraal, I., Gall, H., Peters, G. J., Lankelma, J., and Pinedo, H. M. Phase I and pharmacokinetic studies of high-dose uridine intended for rescue from 5-fluorouracil toxicity. Cancer Res., 44: 5928-5933, 1984.
26. Pizzorno, G., Yee, L., Burtness, B. A., Marsh, J. C., Darnowski, J. W., Chu, M. Y., Chu, S. H., Leffert, J. J., Handschumacher, R. E., and Calabresi, P. Clinical and pharmacological studies of benzylacyclouridine, a uridine phosphorylase inhibitor. Clin. Cancer Res., 4: 1165-1175, 1998.
27. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
28. Watanabe, S., Hino, A., Wada, K., Eliason, J. F., and Uchida, T. Purification, cloning, and expression of murine uridine phosphorylase. J. Biol. Chem., 270: 12191-12196, 1995.
29. Liu, M. P., Srimatkandada, S., Handschumacher, R. E., and Pizzorno, G. Purification of a mammalian uridine phosphorylase and its cDNA Cloning. Proc. Am. Assoc. Cancer Res., 36: 405, 1995.
30. Watanabe, S., and Uchida, T. Cloning and expression of human uridine phosphorylase. Biochem. Biophys. Res. Commun., 216: 265-272, 1995.
31. Takehara, M., Ling, F., Izawa, S., Inoue, Y., and Kimura, A. Molecular cloning and nucleotide sequence of purine nucleoside phosphorylase and uridine phosphorylase genes from Klebsiella sp. Biosci. Biotechnol. Biochem., 59: 1987-1990, 1995.
32. Cacciapuoti, G., Porcelli, M., Bertoldo, C., De Rosa, M., and Zappia, V. Purification and characterization of extremely thermophilic and thermostable 5′-methylthioadenosine phosphorylase from the archaeon Sulfolobus solfataricus. Purine nucleoside phosphorylase activity and evidence for intersubunit disulfide bonds. J. Biol. Chem., 269: 24762-24769, 1994.
33. Langen, P., Etzold, G., Barwolff, B., and Preussel, B. Inhibition of thymidine phosphorylase by 6-amino-thymine and derivatives of 6-amino-uracil. Biochem. Pharmacol., 16: 1833-1837, 1987.
34. Mclvor, R. S., Wohlhueter, R. M., and Plagemann, P. G. Uridine phosphorylase from Novikoff rat hepatoma cells: purification, kinetic properties, and its role in uracil anabolism. J. Cell. Physiol., 122: 397-404, 1985.
35. el Kouni, M. H., el Kouni, M. M., and Naguib, F. N. M. Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implication for chemotherapy with 5-fluoropyrimidines. Cancer Res., 53: 3687-3693, 1993.
36. Maehara, Y., Sakaguchi, Y., Kusumoto, T., Kusumoto, H., and Sugimachi, K. Species differences in substrate specificity of pyrimidine nucleoside phosphorylase. J. Surg. Oncol., 42: 184-186, 1989.
37. Pinedo, H. M., and Peters, G. J. Fluorouracil. Biochemistry and pharmacology. J. Clin. Oncol., 6: 1653-1654, 1988.
38. Klubes, P., Cernal, I., and Meldon, M. A. Uridine rescue from the lethal toxicity of 5-fluorouracil in mice. Cancer Chemother. Pharmacol., 8: 17-21, 1982.
39. Martin, D. S., Stolfi, R. L., Sawyer, R. C., Spiegelman, S., and Young, C. W. High dose 5-fluorouracil with delayed uridine "rescue" in mice. Cancer Res., 42: 3964-3970, 1982.
40. Van Groeningen, C. J., Leyva, A., Kraal I., Peters, G. J., and Pinedo, H. M. Clinical and pharmacokinetic studies of prolonged administration of high-dose uridine intended for rescue from 5-FU toxicity. Cancer Treat. Rep., 70: 745-750, 1986.
41. Seiter, K., Kemeny, N., Martin, D., Schneider, A., Williams, L., Colofiore, J., and Sawyer, R. Uridine allows dose escalation of 5-fluorouracil when given with N-phosphonacetyl-L-aspartate, methotrexate, and leucovorin. Cancer (Phila.), 71: 1875-1881, 1993.
42. Darnowski, J. W., and Handschumacher, R. E. Tissue uridine pools evidence in vivo of a concentrative mechanism for uridine uptake. Cancer Res., 46: 3490-3494, 1986.
43. Darnowski, J. W., and Handschumacher, R. E. Benzylacyclouridine pharmacokinetics, metabolism and biochemical effect in mice. Biochem. Pharmacol., 37: 2613-2619, 1988.